Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BRINCIDOFOVIR
- Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults
- Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
- Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects
- A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
- Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects
- An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola
- Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia
- The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation
- Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
- A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease
- A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus
- A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
- An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease
- The Chimerix CMX001 Registry
- Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection
- A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients
- Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease
- Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses
- Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients
- CMX001 in Post-transplant Patients With BK Virus Viruria
Clinical trials list
click for details